Although parvoviruses are found throughout the animal kingdom, only the human pathogenic B19 virus has so far been shown to possess a limited host range, with erythroid progenitor cells as the main target cells supporting B19 propagation. The underlying mechanism of such erythroid tropism is still unexplained. Synthesis of the NS1 nonstructural protein occurs in permissive and nonpermissive cells, such as megakaryocytes, whereas synthesis of the VP1 and VP2 capsid proteins seems to be restricted to burst-forming units and CFU of erythroid cells. In nonpermissive cells, the NS1 protein is overexpressed and the NS1 RNAs are the predominant RNA species. However, the VP1 and VP2 proteins are not detectable, although the corresponding mRNAs are synthesized. Since all transcripts have part of the 5 untranslated region (5 UTR) in common but distinct 3 UTRs characterizing the nonstructural-and structural-protein mRNAs, we investigated, in transient transfection assays, the possible involvement of the 3 UTR of the capsid protein mRNAs in VP1 and VP2 protein synthesis in nonpermissive Cos cells. The results showed that (i) the 3 UTR of mRNAs coding for the capsid proteins repressed VP1 and VP2 protein synthesis, (ii) the 3 UTR did not affect nuclear export or mRNA stability, and (iii) mRNAs bearing the 3 UTR of the capsid protein mRNAs did not associate with ribosomes at all. Taken together, these results indicate that in nonpermissive cells, the 3 UTR of the capsid protein mRNAs represses capsid protein synthesis at the translational level by inhibiting ribosome loading.
The Parvoviridae family includes many common agents of disease in animals. However, the only known human pathogenic member of this family is the B19 virus, recently reclassified as belonging to a new genus called Erythrovirus. In individuals with underlying hemolytic disorders, B19 virus infection is the primary cause of transient aplastic crisis. In immunocompromised patients, persistent B19 virus infection may lead to pure red cell aplasia and chronic anemia. B19 virus infection in utero can result in fetal death, hydrops fetalis, or congenital anemia. Human erythroid progenitor cells are the main target cells of the B19 virus (22) . However, despite such a remarkable erythroid tropism, B19 virus infection can also impair megakaryocytopoiesis (39) . The disrupted erythropoiesis observed during productive B19 virus infection is initiated by virus replication in erythroid progenitor cells in the bone marrow and is followed by their destruction. In contrast, the etiology of the thrombocytopenia encountered in B19 virus infection is explained by the expression of the B19 virus genome without viral replication, and the expression of the B19 virus genome may be toxic to cell populations that are nonpermissive for viral replication. Thus, human hematopoietic cell culture remains the only in vitro system for B19 virus propagation (29) . The basis of this narrow erythroid specificity is not quite clear, but it is partially mediated by the tissue distribution of the B19 virus cellular receptor, the blood group P antigen (3) . The susceptibility of bone marrow cells to B19 virus infection is known to increase during erythroid differentiation: thus, the CFU consisting of late erythroid progenitor cells (the CFU-E) are more strongly inhibited by B19 virus infection than the burst-forming units consisting of more primitive erythroid progenitor cells (the BFU-E) (41) . Although cellular factors may be involved in viral replication specificity, as in the case of the adenoviruses (43) , permissivity also appears to be controlled at the level of viral gene expression and replication.
Parvoviruses are small, nonenveloped icosahedral viruses containing a linear single-stranded DNA genome of approximately 5 kb, whose sense can be positive or negative. The 5Ј end of the positive-sense strand of the B19 virus genome contains the sequence coding for the NS1 nonstructural protein, and the 3Ј end harbors the sequences coding for the two structural proteins, VP1 and its amino-terminal-truncated version, VP2. The VP2 protein constitutes the major capsid polypeptide, accounting for about 95% of the viral proteins in the virion. The B19 virus transcriptional pattern sets it apart from most of the other parvoviruses (Fig. 1A) . All transcripts are initiated at the single strong left-side promoter called P6. The sequence encoding the NS1 polyadenylation site is located in the middle of the genome, whereas the sequence encoding the VP1 and VP2 polyadenylation site is on the far right side (2, 18, 26) . The existence of a single promoter indicates that viral gene expression is not a function of promoter choice. Moreover, the P6 promoter exhibits strong activity in many cell lines (16) . At least nine polyadenylated RNAs have been identified (4, 26, 35) , and the proteins encoded by five of them have been described (18, 26, 40) . The only unspliced mRNA encodes the NS1 nonstructural protein, a 77-kDa pleiotropic regulating protein which causes cellular toxicity (19, 27) , activates transcription from the P6 promoter (7) , and probably plays a role in viral DNA replication, as documented for the adeno-associated viruses (AAVs) and the minute virus of mice (24, 37) .
Two mRNAs code for each of the two capsid proteins, VP1 and VP2, of 84 and 58 kDa, respectively (30) . The relative amounts of the minor VP1 protein and the major VP2 protein in the viral capsid are regulated in part by the presence of multiple AUG codons upstream of the commonly used translation initiation codon of the VP1 protein (28) . These spurious triplets, which have been shown to be responsible for the reduced translation efficiency of the VP1 mRNAs, are removed by splicing events from the VP2 mRNAs. Consequently, synthesis of the VP2 protein is greatly improved. In addition to these transcripts, small, abundant RNAs of two size classes, whose functions in the virus life cycle are not yet understood, are produced (18, 40) . Synthesis of the NS1 protein occurs in both permissive and nonpermissive cells, whereas synthesis of the VP1 and VP2 proteins seems to be restricted to BFU-E and CFU-E (17, 26) . Permissive cells, which support B19 virus propagation, indeed allow full-length transcription of both the nonstructural-and structural-protein genes, although the capsid protein mRNAs are the predominant RNA species. On the other hand, in nonpermissive cells, the steady-state level of the nonstructural-protein mRNAs is higher than that of the structural-protein mRNAs. The small amount of the capsid protein mRNAs can be explained by the premature arrest of transcription in the middle of the genome, as demonstrated by Liu et al. in transient transfection assays (17) . Thus, in nonpermissive cells, transcription of the nonstructural-protein gene is predominant and leads to overexpression of the corresponding NS1 protein, inducing cell death (20) . Although the level of the capsid protein mRNAs is low, the corresponding VP1 and VP2 proteins are not detectable, indicating that capsid protein synthesis is also regulated at the posttranscriptional level.
In this work, we further investigated the regulation of capsid protein synthesis in nonpermissive cells. We checked for cisacting regulatory elements that might control capsid protein synthesis. Since all the B19 virus transcripts share a common nucleotide sequence at the distal part of the 5Ј untranslated region (5Ј UTR) but have completely distinct 3Ј UTRs characterizing the nonstructural and capsid protein mRNAs (26), we focused on the 3Ј UTR of mRNAs which code for both the VP1 and VP2 proteins. We showed by transient transfection assays that the 3Ј UTR of mRNAs coding for these capsid proteins significantly represses VP1 and VP2 protein synthesis in Cos cells. Our results indicate that this is not the consequence of nuclear retention or of increased instability of the corresponding mRNAs but that the 3Ј UTR of the capsid protein mRNAs regulates capsid protein synthesis at the translational level by inhibiting ribosome loading.
MATERIALS AND METHODS
Construction of recombinant plasmids. The pBS-B19 plasmid is a derivative of the pEMBL-B19 plasmid (31) . It contains the 5,110-bp EcoRI fragment of the B19 virus genome, subcloned at the EcoRI restriction site of the pBluescript II SK (ϩ) plasmid (Stratagene) corresponding to the full-length B19 virus genome, except for the terminal repeat DNA sequences.
To construct the pVP1-3ЈVP and pVP2-3ЈVP plasmids, referred to below as pVP1(2)-3ЈVP, the DNA regions corresponding either to the VP1 open reading frame (ORF) and the DNA sequence coding for the homologous 3Ј UTR (nucleotides [nt] 2438 to 5105 in the B19 virus genome) or to the VP2 ORF and the DNA sequence coding for the VP 3Ј UTR (nt 3119 to 5105 in the B19 virus genome) were amplified by PCR from the pBS-B19 plasmid as a template, with the following primers: VP1 upstream, 5Ј-GGAATTCCCAAGCTTGGGTAGA TTATGAGTAAAAAAAG-3Ј; VP2 upstream, 5Ј-GGAATTCCCAAGCTTGGG CCAAGCATGACTTCAGTT-3Ј; and VP1ϩ2 downstream, 5Ј-GCTCTAGAGC CATCTTGTACCGGAAG-3Ј (characters in italics represent part of the B19 virus sequence). The EcoRI and XbaI restriction sites (underlined) were introduced for further cloning. The PCR products were then digested and inserted between the EcoRI and XbaI restriction sites of the pSG5 plasmid (Stratagene). To construct the pVP1-3ЈSV40 and pVP2-3ЈSV40 plasmids, referred to below as pVP1(2)-3ЈSV40, the DNA regions corresponding to the VP1 and VP2 ORFs (nt 2438 to 4792 and 3119 to 4792 in the B19 virus genome, respectively) were amplified by PCR from the pBS-B19 plasmid as a template, with the upstream primers listed above and the downstream primer 5Ј-GGAATTCCCAAGCTTG GGTGTTTACAATGGGTGCACACG-3Ј. The EcoRI restriction site (underlined) was introduced for further cloning. The PCR products were then digested and inserted into the EcoRI restriction site of the pSG5 plasmid. The pNS1-3ЈSV40 plasmid contains the sequence coding for the NS1 ORF (nt 430 to 2454 in the B19 virus genome), which was amplified by PCR from the pBS-B19 plasmid as a template, with the upstream primer 5Ј-GGAATTCCCAAGCTTG GGCCTAACATGGAGCTATTTAGAGG-3Ј and the downstream primer 5Ј-GG AATTCCCAAGCTTGGGTTTTTACTCATAATCTACAAAGCTTTGC-3Ј, and was inserted into the EcoRI restriction site of the pSG5 plasmid.
The sequences of all the cloned DNA fragments were verified by sequencing with a T7 sequencing kit (Pharmacia Biotech) (35) .
The firefly luciferase (pCMV-Luc) and Escherichia coli ␤-D-galactosidase (pCMV-LacZ) expression plasmids were kindly provided by Uriel Hazan and Marc Alizon (ICGM, Paris, France), respectively.
Cell culture and transient transfection assays. Cos6 cells were grown as monolayers in Dulbecco modified Eagle medium (DMEM; Gibco-BRL) supplemented with 10% heat-inactivated fetal calf serum (Eurobio).
Eight hours before transfection, 1.2 ϫ 10 6 cells were plated onto 100-mmdiameter petri dishes. Transfections were carried out with 12 g of total DNA and 20 g of Lipofectin reagent in 4 ml of Opti-MEM, according to the manufacturer's instructions (Gibco-BRL). All DNA plasmids used for transfection were purified on anion-exchange resin columns (Qiagen). We used 10 g of the relevant VP1 or VP2 expression plasmid together with 2 g of the pCMV-LacZ or pCMV-Luc plasmid per plate. Sixteen hours after transfection, the medium was replaced with fresh DMEM. Cells were harvested at various times after transfection, and RNAs and proteins were extracted. These were analyzed 40 and 64 h posttransfection, respectively, the optimal times for RNA and protein analysis. The pCMV-LacZ and pCMV-Luc plasmids were used as internal transfection efficiency controls. Galactosidase and luciferase activities were quantified by luminometry and colorimetry, respectively, and were standardized as a function of the protein concentration in extracts from cells transfected with the VP1, VP2, or NS1 expression plasmid, as previously described (38) . Each transfection was performed in duplicate, and all experiments were repeated at least three times.
Antibodies. To produce the VP1 and VP2 antibodies, the pET-VP1 and pET-VP2 plasmids were constructed. They contain the 2,370-and 1,689-bp HindIII fragments of the pVP1-3ЈSV40 and pVP2-3ЈSV40 plasmids, respectively, cloned at the XhoI restriction site of the pET-14b plasmid (Novagen), after filling by Klenow treatment. The VP1 and VP2 proteins were produced in E. coli BL21 DE3 and were purified on nickel-exchange resin columns according to the manufacturer's instructions. New Zealand White rabbits were then immunized as previously described (21), and the specific anti-VP1 and anti-VP2 polyclonal antibodies obtained were called Ab-R1 and Ab-R2, respectively.
Protein analysis. The VP1 and VP2 proteins were synthesized in vitro from 1 g of the pVP1-3ЈVP, pVP2-3ЈVP, pVP1-3ЈSV40, or pVP2-3ЈSV40 plasmids incubated in the TNT T7 coupled reticulocyte lysate system (Promega) containing 40 Ci of [ 35 S]methionine (ICN) per assay. The VP1 and VP2 35 S-labeled proteins, which were of the expected size (30), were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) as described below and were revealed by autoradiography of the dried gel.
Indirect immunofluorescence assays were performed with 7 ϫ 10 4 cells per slide. Transfected cells were cytospun, fixed in 3.7% paraformaldehyde for 10 min at 4°C, and then permeabilized with methanol for 5 min at 4°C. Next, cells were incubated with human anti-B19 virus serum, diluted 1:100, from a patient convalescing from B19 virus infection (kindly provided by B. Cohen, Colindale, London, United Kingdom) and were stained with a fluorescein isothiocyanate (FITC)-conjugated goat anti-human antibody (Sanofi Diagnostic Pasteur), diluted 1:100. This serum recognized the VP1 and VP2 proteins but not the NS1 protein, as evidenced by the fact that the indirect immunofluorescence assay was negative on HeLa-NS1-21 cells, in which NS1 protein synthesis was induced by dexamethasone (15) . Concurrently, the rabbit polyclonal antibodies Ab-R1 and Ab-R2 were also used for specific revelation of the VP1 and VP2 proteins. These antibodies were used at a 100-fold dilution, and cells were stained with FITCconjugated goat anti-rabbit antibody (Sanofi Diagnostic Pasteur), diluted 1:100. The NS1 protein was detected with a rabbit polyclonal antibody (kindly provided by C. Astell, University of British Columbia, Vancouver, Canada) used at a 250-fold dilution and was revealed as described above.
For Western blot analysis, cells were heat disrupted at 100°C for 5 min in Laemmli sample buffer (14) . About 50 g of proteins was resolved by SDS-12% PAGE and transferred by electroblotting onto a polyvinylidene difluoride membrane (Immobilon-P; Millipore). The membranes were incubated first with an anti-VP1 or anti-VP1 and -VP2 polyclonal antibody (kindly provided by S. Kajigaya, National Institutes of Health, Bethesda, Md.), diluted 1:50, and then with an alkaline phosphatase-conjugated goat anti-rabbit antibody (BioSys), diluted 1:800. The complexes were stained with NBT (nitroblue tetrazolium)-BCIP (5-bromo-4-chloro-3-indolylphosphate toluidinium) as the substrate (Sigma) (31) .
Radioimmunoprecipitation of proteins was performed as follows: cells were transfected for 56 h and metabolically labeled for 8 h at 37°C with 200 Ci of [ 35 S]methionine per ml in methionine-free DMEM (ICN) supplemented with 10% fetal calf serum. Cells were then lysed for 15 min in ice-cold buffer (50 mM Tris-HCl [pH 7.4], 100 mM NaCl, 5 mM MgCl 2 , 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, 1 g of aprotinin/ml, and 100 g of phenylmethylsulfonyl fluoride/ml). The VP1 and VP2 proteins were immunoprecipitated from cell lysates with human anti-B19 virus serum, diluted 1:10, from the patient convalescing from B19 virus infection for 18 h at 4°C, as previously described (10) . Antigen-antibody complexes were collected on protein A-Sepharose (Sigma) for 2 h at 4°C. Immunoprecipitated proteins were resolved by SDS-PAGE as described above, and the dried gel was submitted to autoradiography. mRNA analysis. For in situ RNA hybridization assays, transfected cells were cytospun, fixed in 3.7% paraformaldehyde for 20 min at 4°C, and permeabilized with 100 mM ethanolamine for 5 min at room temperature. Cells were then incubated either for 2 h at 37°C with 200 U of DNase I/ml in DNase buffer (40 mM Tris-HCl [pH 7.4], 6 mM MgCl 2 , 10 mM NaCl, 10 mM CaCl 2 , and 2 mM dithiothreitol) or for 1 h at 37°C with 100 g of RNase A/ml in RNase buffer (40 mM Tris-HCl [pH 7.5] and 2ϫ SSC [1ϫ SSC is 0.15 M NaCl plus 0.015 M sodium citrate]). The VP1, VP2, and NS1 probes corresponding to the ORF sequences were prepared by PCR using the pVP1-3ЈSV40, pVP2-3ЈSV40, and pNS1-3ЈSV40 plasmids, respectively, as templates and the primers used for cloning. The amplified DNA fragments were purified by using the Wizard PCR Preps DNA purification system (Promega) and were labeled by random priming, by using the DIG DNA labeling kit (Boehringer-Mannheim) in the presence of 0.035 mM [digoxigenin]dUTP. Hybridization and detection of RNA were performed under nondenaturing conditions, as previously described (44) . mRNAs were quantified by Northern blot analysis. Total RNAs were extracted with RNA-B (Bioprobe Systems). Cytoplasmic poly(A)
ϩ RNAs were purified with the Oligotex direct mRNA kit (Qiagen) after lysis of the transfected cells with either Nonidet P-40 or Triton X-100 at a final concentration of 0.5%. Twenty micrograms of total RNAs or 2 g of cytoplasmic poly(A)
ϩ RNAs was loaded onto a 2.2 M formaldehyde-1.2% agarose gel, blotted onto a nitrocellulose filter (Optitran BA-S 85, NC reinforced; Schleicher & Schuell), and hybridized according to standard procedures (8) . The probes used to detect the VP1, VP2, NS1, and human glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNAs were obtained by labeling the 2,354-bp EcoRI fragment of the pVP1-3ЈSV40 plasmid, the 1,673-bp EcoRI fragment of the pVP2-3ЈSV40 plasmid, the 2,024-bp EcoRI fragment of the pNS1-3ЈSV40 plasmid, and the 318-bp SacIBamHI fragment of the pTRI-hGAPDH plasmid (Ambion), respectively, by using a nick translation kit (Boehringer-Mannheim) and [␣-
32 P]dCTP (Amersham). Membranes were hybridized sequentially, first with the VP1, VP2, or NS1 probe and then with the GAPDH probe. After autoradiography, the corresponding mRNAs were quantified by scanning densitometry of the membranes with the GS-525 molecular imager system (Bio-Rad). The results obtained for the VP1, VP2, and NS1 mRNAs were normalized by the correcting factor obtained with the GAPDH probe.
The stability and half-lives of the VP1 and VP2 mRNAs were determined from cells transfected for 40 h with the relevant plasmids and incubated with either 20 g of cycloheximide/ml or 10 g of actinomycin D/ml (46) . Total RNAs were extracted 6 h after addition of cycloheximide, or at hourly intervals until 12 h after addition of actinomycin D, and the VP1 and VP2 mRNAs were quantified by Northern blot analysis as described above.
Distribution of specific mRNAs among polyribosomal fractions. Polyribosomes were prepared from four 100-mm-diameter plates of cells transfected with the relevant plasmids. Sucrose gradient fractionation of polyribosomes was carried out from postmitochondrial supernatants as previously described (6, 11) . Briefly, transfected cells were washed in cold phosphate-buffered saline in the presence of 100 g of cycloheximide/ml and were scraped off from the monolayer in phosphate-buffered saline. Cells were then centrifuged, resuspended in icecold buffer (250 mM sucrose, 50 mM Tris-HCl [pH 7.4], 25 mM KCl, 5 mM MgCl 2 , and 100 g of cycloheximide/ml), and lysed by addition of either Nonidet P-40 or Triton X-100 at a final concentration of 0.5%. Nuclei and mitochondria were pelleted by two successive centrifugations, one at 750 ϫ g and one at 12,000 ϫ g. The postmitochondrial supernatant was layered onto a 10 to 40% linear sucrose gradient in the same buffer containing 2 mM dithiothreitol. After separation by ultracentrifugation in a Beckman SW41 Ti rotor at 40,000 rpm for 75 min at 4°C, 20 fractions of identical volume were collected from the top of the gradient. Each fraction was incubated with 100 g of proteinase K/ml and 1% SDS, and the RNA was extracted with phenol-chloroform and precipitated with ethanol. The RNA from each fraction was resuspended in 10 mM Tris-HCl (pH 7.4)-1 mM EDTA-50 U of RNasin (Promega)/ml. The distribution and quantification of the various mRNAs in the different fractions were then determined on Northern blots, as described above.
RESULTS

Inhibition of capsid protein gene expression.
To determine to what extent the sequence coding for the 3Ј UTR of capsid protein mRNAs is involved in regulating the expression of the homologous gene, we constructed the pVP1-3ЈVP, pVP2-3ЈVP, pVP1-3ЈSV40, and pVP2-3ЈSV40 plasmids (Fig. 1B) . In the pVP1-3ЈVP and pVP2-3ЈVP plasmids, the DNA sequence coding for the VP1 and the VP2 ORFs and the downstream homologous 3Ј UTR of the capsid protein mRNAs were cloned in the pSG5 plasmid controlled by the simian virus 40 (SV40) early promoter. We decided not to preserve the homologous DNA sequence coding for the 5Ј UTR in our plasmids, as it includes multiple AUG codons upstream of the commonly used translation initiation codon of the VP1 protein (28) . In the pVP1-3ЈSV40 and pVP2-the DNA sequence coding for the 3Ј UTR of the capsid protein mRNAs was replaced by that of the SV40 early mRNAs. The pNS1-3ЈSV40 plasmid, which we constructed as a control, contained the NS1 ORF instead of the VP1(2) ORF.
Cos cells were transfected with the pVP1-3ЈVP, pVP2-3ЈVP, pVP1-3ЈSV40, or pVP2-3ЈSV40 plasmid. The pNS1-3ЈSV40 plasmid was used as a positive control for viral gene expression. The galactosidase (pCMV-LacZ) or luciferase (pCMV-Luc) expression plasmid was included in each transfection as an internal control for transfection efficiency. Cells were harvested 64 h posttransfection, and the presence of the VP1 and VP2 proteins was revealed by immunofluorescence assay using human anti-B19 virus serum from a patient convalescing from B19 virus infection. No detectable fluorescence was seen in cells transfected with the pVP2-3ЈVP plasmid, whereas about 5% of the cells transfected with the pVP2-3ЈSV40 plasmid exhibited a fluorescent pattern (Fig. 2A) . Identical data (not shown) were obtained for cells transfected with the VP1 plasmids. Similar results were obtained with the specific Ab-R1 and Ab-R2 polyclonal antibodies, directed against VP1 and VP2, respectively (data not shown). Furthermore, the NS1 protein was detected in about 30% of the cells which were transfected with the pNS1-3ЈSV40 plasmid and incubated with a specific NS1 polyclonal antibody; this percentage reflects the transfected yield, because galactosidase activity was detected in situ in about 30% of the transfected cells in all experiments. The ratios of galactosidase and luciferase activities to total protein concentration were 0.21 Ϯ 0.03 and 1,103,676 Ϯ 71,395, respectively. No fluorescence was detected either in cells transfected with the pSG5 plasmid or in the control mocktransfected cells incubated with the antibodies.
These results were confirmed by Western blot analysis with anti-VP1 and anti-VP1 and -VP2 polyclonal antibodies to reveal the VP1 and VP2 proteins, respectively. As shown in Fig.  2B , no protein was detectable in cells transfected with the pVP1-3ЈVP or pVP2-3ЈVP plasmid, whereas in cells transfected with the pVP1-3ЈSV40 or pVP2-3ЈSV40 plasmid, the VP1 and VP2 proteins of 84 and 58 kDa, respectively, were detected. No protein was detected in the cells transfected with the pSG5 plasmid or in the control mock-transfected cells, but the Western blot pattern of the nonspecific signals was the same as that of cells transfected with the pVP1-3ЈVP or pVP2-3ЈVP plasmid. These results were also confirmed by radioimmunoprecipitation assays (data not shown).
Taken together, these results show that the VP1 and VP2 proteins are synthesized only in Cos cells transfected with the pVP1-3ЈSV40 or pVP2-3ЈSV40 plasmid, not in Cos cells transfected with the pVP1-3ЈVP or pVP2-3ЈVP plasmid. This suggests that the sequence coding for the 3Ј UTR of the capsid protein mRNAs is indeed involved in repressing capsid protein gene expression.
No inhibition of transcription or nucleocytoplasmic transport, and no destabilization of transcripts. To test the possibility that the repression of capsid protein synthesis in transfected cells was due to the inhibition of transcription of the corresponding genes, we explored Cos cells transfected with the pVP2-3ЈVP or pVP2-3ЈSV40 plasmid for the presence of the capsid protein mRNAs, using in situ RNA hybridization. The results showed that the digoxigenin-labeled VP2 probe hybridized with about 30% of the cells transfected with the pVP2-3ЈVP or pVP2-3ЈSV40 plasmid (Fig. 3A) . Identical data (not shown) were obtained for cells transfected with the VP1 plasmids. No hybridization signal was detected in cells incubated with RNase A prior to hybridization. The digoxigeninlabeled NS1 probe also hybridized with about 30% of the cells transfected with the positive-control pNS1-3ЈSV40 plasmid, a result consistent with the immunofluorescence data. The cells transfected with the pSG5 plasmid and the control mock-transfected cells did not hybridize with the probes (data not shown). These results indicate that the VP1 and VP2 genes are transcribed, even from the transfected pVP1-3ЈVP and pVP2-3ЈVP plasmids. Therefore, the absence of capsid protein synthesis is not due to the inhibition of transcription but might result from inefficient nucleocytoplasmic transport of the corresponding mRNAs. As shown in Fig. 3A , the hybridization signal varied from cell to cell, ranging from staining of intranuclear foci only to overall staining of both the nucleus and the cytoplasm of cells transfected with the pVP2-3ЈVP, pVP2-3ЈSV40, or pNS1- 3ЈSV40 plasmid. However, the same percentage of nucleocytoplasmic staining was observed in cells transfected with the pVP2-3ЈVP, pVP2-3ЈSV40, or pNS1-3ЈSV40 plasmid, indicating that there was no defect in the nuclear export of the capsid protein mRNAs containing the homologous 3Ј UTR. Identical results were obtained for cells transfected with the pVP1-3ЈVP and pVP1-3ЈSV40 plasmids (data not shown).
To ascertain whether or not the failure to detect the capsid proteins in Cos cells transfected with the pVP1-3ЈVP or pVP2-3ЈVP plasmid was due to a low level of the corresponding mRNAs, we estimated the amount of the VP2 cytoplasmic polyadenylated RNAs in cells transfected with the pVP2-3ЈVP or pVP2-3ЈSV40 plasmid. The pNS1-3ЈSV40 plasmid was used as a positive control. The results of Northern blot analysis (Fig.  3B) showed that there was no obvious difference in the amount of the VP2 cytoplasmic mRNAs between cells transfected with the pVP2-3ЈVP plasmid and cells transfected with the pVP2-3ЈSV40 plasmid. The difference in size between the VP2 mRNAs transcribed from the pVP2-3ЈVP plasmid and those transcribed from the pVP2-3ЈSV40 plasmid was due to the difference in size between the corresponding 3Ј UTRs.
Identical results were obtained for cells transfected with the VP1 plasmids (data not shown). In addition, the results of cycloheximide or actinomycin D treatment of the transfected cells revealed no obvious difference between the synthesis or degradation rates of the VP2-3ЈVP and VP2-3ЈSV40 mRNAs, on the one hand, and those of the VP1-3ЈVP and VP1-3ЈSV40 mRNAs, on the other (data not shown).
Taken together, these results indicate that the absence of capsid protein synthesis in Cos cells transfected with the pVP1-3ЈVP or pVP2-3ЈVP plasmid cannot be the result of the inhibition of transfected plasmid transcription, of nuclear retention, or of destabilization of the corresponding synthesized mRNAs.
No inhibition of capsid protein mRNA translation in vitro. To explore the ability of the pVP1-3ЈVP and pVP2-3ЈVP plasmids to regulate the synthesis of the VP1 and VP2 proteins, these plasmids were used as templates in in vitro coupled transcription and translation in the presence of reticulocyte lysate. As shown in Fig. 4 , the VP1 and VP2 proteins were of the expected sizes, i.e., 84 and 58 kDa, respectively, and they were synthesized from the capsid protein expression plasmids whether they contained the DNA sequence coding for the 3Ј UTR of the capsid protein mRNAs or that coding for the 3Ј UTR of the SV40 early mRNAs. This finding indicates that in reticulocyte lysate, the plasmids containing the DNA sequence coding for the 3Ј UTR of the capsid protein mRNAs are transcribed, and the corresponding mRNAs are able to regulate protein synthesis. It also shows that the 3Ј UTR of the capsid protein mRNAs does not inhibit translation in an in vitro system using erythroid cell lysate.
Inhibition of capsid protein mRNA translation in vivo. The results described above strongly suggest that in cells transfected with the pVP1(2)-3ЈSV40 or pVP1(2)-3ЈVP plasmid, VP1 and VP2 protein synthesis is regulated at the translational level. To verify this hypothesis, the recruitment of the corresponding mRNAs by the translational apparatus was investigated. Cos cells were transfected with the pVP2-3ЈVP or pVP2-3ЈSV40 plasmid, or with the pNS1-3ЈSV40 positive-control plasmid. Forty hours after transfection, postmitochondrial supernatants were separated into 20 fractions after centrifugation on sucrose gradients, and total RNAs were extracted from these fractions. The distribution of the various mRNAs of interest among the different fractions was visualized by Northern blot analysis and quantified by densitometry scanning of ϩ RNAs. Cytoplasmic poly(A) ϩ RNAs were purified from Cos cells transfected for 40 h with the indicated plasmids. Each transfection was performed in duplicate, and all experiments were repeated three times. Two micrograms of each mRNA preparation was separated by electrophoresis through a formaldehyde-agarose gel and blotted onto a nitrocellulose membrane. The membranes were first hybridized to a 32 P-labeled VP2 probe (left panel) or an NS1 probe (right panel) and were submitted to autoradiography for 1 day (upper panels). The same membranes were then hybridized to a 32 P-labeled GAPDH probe as a control of the mRNA level and were submitted to autoradiography for 1 h (lower panels). The amount of probe hybridized with the VP2 mRNAs was normalized to the extent of hybridization with the GAPDH probe. Arrows to the right of the panels indicate the corresponding mRNAs. The position of the 18S ribosomal RNA is indicated to the left of each panel. the membranes. The results (Fig. 5B and C) show that the VP2-3ЈVP mRNAs were distributed among fractions 1 to 7 and that more than 66% of the VP2-3ЈVP mRNAs were contained in fractions 1 and 2, which corresponded to free mRNA molecules. The remaining mRNA molecules were found in fractions 3 to 7, corresponding to mRNAs associated with one 40S ribosomal subunit (fractions 3 and 4) or with one ribosome (fractions 6 and 7). No mRNA molecules were associated with active polyribosomes (fractions 8 to 20). This means that the VP2-3ЈVP mRNA molecules are not engaged in translation at all. On the other hand, the VP2-3ЈSV40 mRNAs were distributed unevenly among fractions 3 to 20. About 27% of the VP2-3ЈSV40 mRNA molecules were associated with the 40S ribosomal subunit, 31% were associated with 80S ribosomes, and 42% were associated with polyribosomes. Figure 5C (upper panel) clearly shows that all the VP2-3ЈSV40 mRNA molecules were actively engaged in translation, whereas the VP2-3ЈVP mRNA molecules were not. The pNS1-3ЈSV40 plasmid was used as a positive control, and the results in Fig. 5B show that the NS1-3ЈSV40 mRNA molecules were unevenly distributed among fractions 4 to 20. Only 13 and 20% of the NS1-3ЈSV40 mRNAs were associated with the 40S ribosomal subunit and with 80S ribosomes, respectively. More than 67% were associated with polyribosomes actively engaged in translation. The distribution of the GAPDH mRNAs among polyribosomal subfractions was determined in each experiment as a control of mRNA distribution. The results in Fig. 5C (lower panel) show no significant difference in the recruitment of the GAPDH mRNAs by the translational apparatus between Cos cells transfected with the various plasmids. These data reveal that the VP2 mRNA molecules which contain the homologous 3Ј UTR are not recruited at all by active polyribosomes. On the contrary, the VP2 mRNA molecules which contain the heterologous 3Ј UTR of SV40 mRNAs are efficiently translated. This indicates that the 3Ј UTR of the capsid protein mRNAs inhibits ribosome loading and that the replacement of the 3Ј UTR of the capsid protein mRNAs with that of the SV40 mRNAs abolishes this inhibition.
DISCUSSION
We examined the role of the 3Ј UTR of the capsid protein mRNAs in regulating the translation of the capsid protein mRNAs in nonpermissive cells. We used Cos cells because even though human megakaryocytes are the main nonpermissive cells in vivo, the transfection of the B19 virus genome into Cos cells reproduces the nonpermissive viral transcriptional and translational pattern (1, 17, 27) . The data obtained from our transient expression assays show that the 3Ј UTR of the capsid protein mRNAs inhibits translation of the corresponding mRNAs. We found that in Cos cells transfected with the VP1 or VP2 expression plasmid harboring the sequence coding for the homologous 3Ј UTR, the capsid proteins were not detectable. This cannot be due to the inhibition of transcription, because the corresponding mRNAs were synthesized. In addition, the results of in situ hybridization showed no significant difference between the relative nucleocytoplasmic distributions of the VP1 and VP2 transcripts, whether or not they contained the 3Ј UTR of the capsid protein mRNAs. Furthermore, the results of Northern blotting revealed that the VP1 and VP2 mRNAs synthesized from plasmids, with or without the sequence coding for the homologous 3Ј UTR, were degraded at the same rate, as shown by their very similar steadystate amounts. Therefore, the absence of the capsid proteins in cells transfected with the pVP1-3ЈVP or pVP2-3ЈVP plasmid cannot result from the inhibition of the nucleocytoplasmic transport of the transcripts or from a decrease in the stability of the VP1-3ЈVP or pVP2-3ЈVP mRNAs. Taken together, these results strongly suggest that in transfected Cos cells, the capsid protein mRNAs are differentially translated, depending on their 3Ј UTR. In this connection, polyribosome analysis FIG. 5 . Recruitment of the VP2 or NS1 mRNAs by the translational apparatus. Cos6 cells were transfected for 40 h with the pVP2-3ЈVP, pVP2-3ЈSV40, or pNS1-3ЈSV40 plasmid. The postmitochondrial supernatants were layered onto 10 to 40% linear sucrose gradients. After centrifugation, 20 fractions of identical volume were collected. RNAs were extracted from each fraction, and the distribution of VP2 or NS1 mRNAs among the different fractions was revealed by Northern blotting with the relevant 32 P-labeled VP2-or NS1-specific DNA probe. Membranes were sequentially hybridized with the corresponding VP2 or NS1 probe and were submitted to autoradiography for 1 day. All membranes were then hybridized to the 32 P-labeled GAPDH probe as a control for mRNA distribution and were submitted to autoradiography for 1 day. (A) Typical UV absorbance profile of polyribosomes from Cos cells transfected with the pVP2-3ЈSV40 plasmid. Fraction numbers are indicated under the profile, with fraction 1 at the top of the gradient. The 40S, 60S, and 80S positions, as well as the positions of polyribosomes, are specified. (B) Autoradiograms of membranes after hybridization with the VP2 probe (top and middle panels) or with the NS1 probe (bottom panel). On the right, VP2-3ЈVP, VP2-3ЈSV40, and NS1-3ЈSV40 refer to mRNAs transcribed from the pVP2-3ЈVP, pVP2-3ЈSV40, and pNS1-3ЈSV40 transfected plasmids, respectively. (C) Quantification of the VP2-3ЈVP, VP2-3ЈSV40, and NS1-3ЈSV40 mRNAs among the polyribosomal fractions (upper panel) and of control GAPDH mRNAs from each experiment (lower panel). After autoradiography, the indicated mRNAs were quantified in each fraction by scanning densitometry of the corresponding membranes on a molecular imager system. Results are given as the amount of total radioactivity in each fraction expressed as a percentage of the sum of the radioactivity in all 20 fractions. indeed showed that the capsid protein mRNA molecules which contained the 3Ј UTR of SV40 early mRNAs were associated with a large number of ribosomes, indicating that they are efficiently translated. On the other hand, the capsid protein mRNA molecules containing the 3Ј UTR of the VP1 and VP2 mRNAs had no connection whatever with any ribosomal subunit. This suggests that the 3Ј UTR of the VP1 and VP2 mRNAs suppresses capsid protein mRNA translation by inhibiting one of the steps required to bind the 40S ribosomal subunit. If true, this would suffice to explain the complete inhibition of capsid protein synthesis in transfected Cos cells. Other 3Ј UTRs have been shown to inhibit protein synthesis, and some were found to affect mRNA nucleocytoplasmic transport specifically (9, 32, 33) . However, this was not the case here for the 3Ј UTR of the B19 virus capsid protein mRNAs in transfected Cos cells. Many of the elements inside transcripts that control mRNA stability have been localized in the 3Ј UTR (5) . Analysis of the 3Ј UTR sequence of the B19 virus capsid protein mRNAs revealed the presence of three AUUUA sequences (AU-rich elements [AREs]) already described in the 3Ј UTRs of several cellular and viral mRNAs (34) . These sequences are known to promote mRNA degradation by stimulating rapid deadenylation, at speeds depending on the cellular context (23, 36) . However, these specific elements did not seem to affect VP1 or VP2 mRNA turnover in transfected Cos cells. Other 3Ј UTRs have been shown to affect translational initiation, for example, during the early development or differentiation of somatic cells (12) . Translational repression via the 3Ј UTR can be achieved by several mechanisms (45) . One example is the 3Ј UTR of the rabbit erythroid 15-lipoxygenase mRNA, which helps to inhibit translation during the early stages of erythropoiesis (25) . The present findings for in vitro coupled transcription-translation show that capsid proteins are synthesized from VP1 and VP2 mRNAs containing the 3Ј UTR of the capsid protein mRNAs, indicating that the 3Ј UTR of the capsid protein mRNAs does not inhibit translation in rabbit reticulocyte lysate. This suggests that cellular factors are involved either in inhibiting the translation of the capsid protein mRNAs in Cos cells or in stimulating the translation in erythroid cell lysate. It also suggests that the susceptibility of erythroid cells to B19 virus infection depends on one or several of the cellular factors involved in the translation of viral mRNAs.
Our results demonstrate that the inhibition of capsid protein synthesis in Cos cells transfected with the pVP1(2)-3ЈVP plasmids is due to the 3Ј UTR of the capsid protein mRNAs, which prevents the translation of the corresponding mRNAs. However, the 3Ј UTR of these mRNAs is not the only element in the VP1 and VP2 mRNAs which contributes to the inhibition of capsid protein synthesis. Under our experimental conditions, the NS1 and the VP1 as well as the VP2 mRNAs synthesized from the pNS1-3ЈSV40 and pVP1(2)-3ЈSV40 plasmids, which contain the sequence coding for the 3Ј UTR of the SV40 early mRNAs, were detected in about 30% of the transfected Cos cells. Nevertheless, the NS1 protein was detected in 30% of the cells, whereas the VP1 and VP2 proteins were detected in only 5% of the cells. This was not due to the presence of an inefficient translation initiation codon in the capsid protein mRNAs, because the replacement of the weak AUG initiation codon with the GCCACCAUGG Kozak consensus sequence (13) did not increase VP1 or VP2 protein synthesis (data not shown). Furthermore, polyribosome analysis showed that the NS1-3ЈSV40 mRNA molecules were more efficiently translated than the VP2-3ЈSV40 mRNA molecules. This could suggest that the ORF is also involved in regulating capsid protein mRNA translation. Although it has been demonstrated that the AAV rep gene acts in cis or in trans as a translational inhibitor of mRNAs from the AAV p40 promoter (42) , the NS1 protein of the B19 virus could stimulate translation of mRNAs containing the 3Ј UTR of the SV40 early mRNAs. However, we failed to detect any stimulation in double transfection experiments with the pNS1-3ЈSV40 and pVP2-3ЈSV40 plasmids (data not shown).
Taken together, these findings could indicate that the inhibitory effect of the 3Ј UTR of the capsid protein mRNAs on the translation of the VP1(2)-3ЈVP mRNAs is due to a mechanism which involves the 3Ј UTR and possibly the homologous ORF. Computer analysis using the RNA folding form program by M. Zuker revealed the formation of a structured region which might participate in the inhibition of capsid protein mRNA translation in nonpermissive cells. Mutants in the 3Ј UTR and the ORF will be useful for determination of the sequence involved in inhibiting capsid protein mRNA translation and for identification of the cellular factor(s) necessary for structural protein mRNA translation. In conclusion, the present results showed that the translation of the mRNAs synthesized by our plasmids containing the sequence coding for the 3Ј UTR of the capsid protein mRNAs was inhibited. The same might apply to the infection of nonpermissive cells by the B19 virus. Consequently, in nonpermissive cells, the true B19 virus mRNAs might not be translated because of their 3Ј UTR.
